Clinical Trial Update: Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel with gemcitabine for relapsed small cell lung cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Muhammad Furqan | Conditions: Small Cell Lung Cancer (SCLC) | Phase 2 | Status: COMPLETED | Results posted: 2023-07-21